Schedule 13G ownership disclosure

XERIS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 98422L107

Event date: 2020-06-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,487,581
Percent of class
5.2600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001011438-20-000164
Form type
SC 13G
Filer
SOROS FUND MANAGEMENT LLC
CIK
CIK 1029160
Filed
Jul 10, 2020
Reporting period
Jun 30, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub